Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Beata Sweryda‐Krawiec
Observed names:
B. Sweryda-Krawiec,
Beata Sweryda-Krawiec
Institutions:
Cerulean Pharma (United States),
Tarveda Therapeutics (United States)
Observed institutions:
University of North Texas,
Texas Christian University,
Clarkson University,
Cerulean Pharma (United States),
Tarveda Therapeutics (United States),
University of Warsaw,
Clemson University
show all 7
OpenAlex ID:
A5077500087
A New Interpretation of Serum Albumin Surface Passivation
2004
·
Beata Sweryda-Krawiec
, Halagowder Devaraj
, et al.
·
Langmuir
·
154
Targeting the Somatostatin Receptor 2 with the Miniaturized Drug Conjugate, PEN-221: A Potent and Novel Therapeutic for the Treatment of Small Cell Lung Cancer
2019
·
Kerry A. Whalen
, Brian H. White
, et al.
·
Molecular Cancer Therapeutics
·
81
Surface Modification of Silicon Nanocrystallites by Alcohols
1999
·
Beata Sweryda-Krawiec
, Thierry Cassagneau
, et al.
·
The Journal of Physical Chemistry B
·
72
Discovery of an SSTR2-Targeting Maytansinoid Conjugate (PEN-221) with Potent Activity in Vitro and in Vivo
2019
·
Brian H. White
, Kerry Whalen
, et al.
·
Journal of Medicinal Chemistry
·
58
A Comparison of Porous Silicon and Silicon Nanocrystallite Photoluminescence Quenching with Amines
1996
·
Beata Sweryda-Krawiec
, Robin R. Chandler-Henderson
, et al.
·
The Journal of Physical Chemistry
·
54
Steric Considerations in the Amine-Induced Quenching of Luminescent Porous Silicon
1995
·
Robin R. Chandler-Henderson
, Beata Sweryda-Krawiec
, et al.
·
The Journal of Physical Chemistry
·
53
Tumor Selective Silencing Using an RNAi-Conjugated Polymeric Nanopharmaceutical
2016
·
Sonke Svenson
, Roy I. Case
, et al.
·
Molecular Pharmaceutics
·
27
Robust polymer colloidal crystal photonic bandgap structures
2000
·
Stephen H. Foulger
, Sanjay Kotha
, et al.
·
Optics Letters
·
19
Ultrathin Electroactive Junctions Assembled from Silicon Nanocrystallites and Polypyrrole
1999
·
Beata Sweryda-Krawiec
, Thierry Cassagneau
, et al.
·
Advanced Materials
·
12
Rectifying Self-Assembled Ultrathin Films
2000
·
T. P. Cassagneau
, B. Sweryda-Krawiec
, et al.
·
MRS Bulletin
·
11
Discovery of a Novel Cabazitaxel Nanoparticle–Drug Conjugate (CRLX522) with Improved Pharmacokinetic Properties and Anticancer Effects Using a β-Cyclodextrin–PEG Copolymer Based Delivery Platform
2019
·
Chester A. Metcalf
, Sonke Svenson
, et al.
·
Journal of Medicinal Chemistry
·
9
Ion interaction chromatography with nonylamine reagent for the determination of nitrite and nitrate in natural waters
1993
·
Ewa Pobozy
, Beata Sweryda-Krawiec
, et al.
·
Journal of Chromatography A
·
7
The Quenching of Porous Silicon Photoluminescence by Group 15 Triaryl Derivatives: Effects of Surface Photo‐oxidation
1995
·
Beata Sweryda‐Krawiec
, Jeffery L. Coffer
·
Journal of The Electrochemical Society
·
6
Abstract 3674: Pentarins: Improved tumor targeting through nanoparticle encapsulation of miniaturized biologic drug conjugates
2015
·
Mark T. Bilodeau
, Rajesh Shinde
, et al.
·
Cancer Research
·
5
Time-Resolved Spectroscopic Studies of the Photoluminescence of Nanoporous Silicon: Effects of Lewis Acid/Base Exposure
2002
·
Beata Sweryda-Krawiec
, Jeffery L. Coffer
, et al.
·
Journal of Cluster Science
·
4
Abstract 39: Discovery of PEN-221, an SSTR2-targeting maytansinoid conjugate with potent activity in vitro and in vivo
2017
·
Brian H. White
, Patrick Bazinet
, et al.
·
Cancer Research
·
3
Abstract 4328: Epigenetic modulation of SSTR2 expression provides the potential to broaden PEN-221 treatment population
2019
·
Samantha Perino
, James Quinn
, et al.
·
Cancer Research
·
1
Supplemental Materials and Methods from Targeting the Somatostatin Receptor 2 with the Miniaturized Drug Conjugate, PEN-221: A Potent and Novel Therapeutic for the Treatment of Small Cell Lung Cancer
2023
·
Kerry A. Whalen
, Brian H. White
, et al.
Supplemental Table S2 from Targeting the Somatostatin Receptor 2 with the Miniaturized Drug Conjugate, PEN-221: A Potent and Novel Therapeutic for the Treatment of Small Cell Lung Cancer
2023
·
Kerry A. Whalen
, Brian H. White
, et al.
Supplemental Figure S2 from Targeting the Somatostatin Receptor 2 with the Miniaturized Drug Conjugate, PEN-221: A Potent and Novel Therapeutic for the Treatment of Small Cell Lung Cancer
2023
·
Kerry A. Whalen
, Brian H. White
, et al.
Supplemental Figure S4 from Targeting the Somatostatin Receptor 2 with the Miniaturized Drug Conjugate, PEN-221: A Potent and Novel Therapeutic for the Treatment of Small Cell Lung Cancer
2023
·
Kerry A. Whalen
, Brian H. White
, et al.
Supplemental Table S1 from Targeting the Somatostatin Receptor 2 with the Miniaturized Drug Conjugate, PEN-221: A Potent and Novel Therapeutic for the Treatment of Small Cell Lung Cancer
2023
·
Kerry A. Whalen
, Brian H. White
, et al.
Supplemental Figure S3 from Targeting the Somatostatin Receptor 2 with the Miniaturized Drug Conjugate, PEN-221: A Potent and Novel Therapeutic for the Treatment of Small Cell Lung Cancer
2023
·
Kerry A. Whalen
, Brian H. White
, et al.
Supplemental Figure S1 from Targeting the Somatostatin Receptor 2 with the Miniaturized Drug Conjugate, PEN-221: A Potent and Novel Therapeutic for the Treatment of Small Cell Lung Cancer
2023
·
Kerry A. Whalen
, Brian H. White
, et al.
Supplemental Figure S3 from Targeting the Somatostatin Receptor 2 with the Miniaturized Drug Conjugate, PEN-221: A Potent and Novel Therapeutic for the Treatment of Small Cell Lung Cancer
2023
·
Kerry A. Whalen
, Brian H. White
, et al.
Show more works
View as search
Works count:
36
Citation count:
576
H-index:
10
I10-index:
10
Year
Topic
Type